PNC Financial Services Group’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-370
Closed -$1.73K 5301
2025
Q4
$1.73K Buy
+370
New +$1.68K ﹤0.01% 4564

Other funds holding SOPH

PNC Financial Services Group's SOPH Position: Q1 2026 in Review

PNC Financial Services Group sold out of SOPHiA GENETICS (SOPH) in Q1 2026, closing a stake of 370 shares — an estimated $1.73K sold.

PNC Financial Services Group first reported a position in SOPH in Q4 2025 and held it in 1 quarter. The position peaked at $1.73K in Q4 2025. 49 funds tracked by Wall St. Rank hold SOPH as of Q1 2026.

  • PNC Financial Services Group reported no remaining SOPHiA GENETICS position as of Q1 2026 after selling out during the quarter.
  • PNC Financial Services Group sold 370 SOPHiA GENETICS shares in Q1 2026, an estimated $1.73K.
  • PNC Financial Services Group first reported a position in SOPHiA GENETICS in Q4 2025 and held it in 1 quarter.
  • PNC Financial Services Group's SOPHiA GENETICS position peaked at $1.73K in Q4 2025.
  • 49 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.